Search Results - "Abelson, Mark B."

Statistical Evaluation of Smartphone-Based Automated Grading System for Ocular Redness Associated with Dry Eye Disease and Implications for Clinical Trials.

Authors: Rodriguez, John D Hamm, Adam Bensinger, Ethan et al.

Source: Clinical Ophthalmology. Mar2025, Vol. 19, p907-914. 8p.

Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials.

Authors: Rodriguez, John D Kerti, Samantha Hamm, Adam et al.

Source: Clinical Ophthalmology. Aug2024, Vol. 18, p2193-2203. 11p.

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge.

Authors: Abelson, Mark B. Spangler, Dennis L. Epstein, Arthur B. et al.

Source: Current Eye Research. Dec2007, Vol. 32 Issue 12, p1017-1022. 6p. 3 Charts, 1 Graph.

ARVO Goes to The Emerald City.

Authors: Abelson, Mark B.¹

Source: Review of Ophthalmology. Jul2013, Vol. 20 Issue 7, p50-55. 5p.

Serendipitous Drug Development.

Authors: Abelson, Mark B. Howe, Amanda J.

Source: Review of Ophthalmology. Mar2009 Part 1 of 2, Vol. 16 Issue 3, p54-58. 4p.

Balancing Biomarker Applications: Each of these indirect measures of therapeutic efficacy comes with its own strengths and weaknesses.

Authors: Abelson, Mark B. Dimopoulos, George Ousler, George et al.

Source: Review of Ophthalmology. Aug2017, Vol. 24 Issue 8, p46-50. 4p.

Blink patterns and lid-contact times in dry-eye and normal subjects.

Authors: Ousler 3rd, George W. Abelson, Mark B. Johnston, Patrick R. et al.

Source: Clinical Ophthalmology. 2014, Vol. 8, p869-874. 6p.

Nobel Therapeutics And Ophthalmology.

Authors: Abelson, Mark B. McLaughlin, James

Source: Review of Ophthalmology. Feb2013, Vol. 20 Issue 2, p52-55. 4p.

One or Two More Pearls ... After 23 years, Therapeutic Topics comes to an end with an installment filled with several decades' worth of wisdom.

Authors: Abelson, Mark B.^1,2

Source: Review of Ophthalmology. Oct2017, Vol. 24 Issue 10, p56-58. 3p.

Breaking the Barrier: Allergy, Dry Eye and Contact Lenses.

Authors: Abelson, Mark B. Leung, Stephanie Maffei, Ciera

Source: Review of Optometry. 3/15/2008 Review of, Vol. 145, p15-18. 4p.

Is it Dry Eye or Allergy?

Authors: Abelson, Mark B. Lilyestrom, Lauren

Source: Review of Optometry. 8/15/2007 Part 1 of 2, Vol. 144 Issue 8, p75-83. 6p.

Right Between Your Eyes.

Authors: Abelson, Mark B. Hollander, David A. Hertsenberg, Andrew

Source: Review of Ophthalmology. Oct2016, Vol. 23 Issue 10, p96-98. 3p.

The Hows and Whys of Pharmacokinetics.

Authors: Abelson, Mark B.¹

Source: Review of Ophthalmology. Oct2015, Vol. 22 Issue 10, p74-76. 3p.

Author's response.

Authors: Johnston, Patrick R. Rodriguez, John Lane, Keith J. et al.

Source: Clinical Ophthalmology. Apr2013, Vol. 7, p794-794. 1p.

Does Allergy Article Pass This Challenge Test?

Authors: Abelson, Mark B.

Source: Review of Ophthalmology. Feb2008, Vol. 15 Issue 2, p15-18. 3p.

The Highlights From ARVO 2017: A review of the hottest research in therapeutics for both the front and back of the eye.

Authors: Abelson, Mark B. Hollander, David

Source: Review of Ophthalmology. Jul2017, Vol. 24 Issue 7, p48-52. 5p.

Heighten Dry-Eye Situational Awareness.

Authors: Abelson, Mark B. Ousler, George Plumer, Annie

Source: Review of Ophthalmology. Dec2005, Vol. 12 Issue 12, p64-66. 3p.

How Do You Quantify The Qualitative?

Authors: Abelson, Mark B. Smith, Lisa M. Hollander, David A. et al.

Source: Review of Ophthalmology. Aug2016, Vol. 23 Issue 8, p48-51. 4p.

The Hottest Topics From ARVO 2016.

Authors: Abelson, Mark B. Hollander, David

Source: Review of Ophthalmology. Jul2016, Vol. 23 Issue 7, p46-51. 6p.

Delivering a Rocky Mountain ARVO.

Authors: Abelson, Mark B.¹

Source: Review of Ophthalmology. Jul2015, Vol. 22 Issue 7, p56-63. 5p.